Raquel Boix

Raquel Boix

Auto-generated profile, based on publicly available information

Raquel Boix

Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Environmental Research
Verified
Journal Article
Closed access
MMMa José Medrano
Ma José Medrano
RBRaquel Boix
Raquel Boix
PRPastor-Barriuso Roberto
Pastor-Barriuso Roberto
MPMargarita Palau
Margarita Palau
JDJavier Damián
Javier Damián
ANAna Navas-Acien
Ana Navas-Acien

19 October 2009 in BMC Neurology
Verified
Journal Article
Open access
PDF file
JPJesús de Pedro-Cuesta
Jesús de Pedro-Cuesta
JVJavier Virués-Ortega
Javier Virués-Ortega
SVSaturio Vega
Saturio Vega
MSManuel Seijo-Martínez
Manuel Seijo-Martínez
PSPedro Saz
Pedro Saz
JFJosé Luis Del Barrio Fernández
José Luis Del Barrio Fernández
This study describes the prevalence of dementia and major dementia subtypes in Spanish elderly. We identified screening surveys, both published and unpublished, in Spanish populations, which fulfilled specific quality criteria and targeted prevalence of dementia in populations aged 70 years and above. Surveys covering 13 geographically different populations were selected (prevalence period: 1990-2008). Authors of original surveys provided methodological details of their studies through a systematic questionnaire and also raw age-specific data. Prevalence data were compared using direct adjustment and logistic regression. The reanalyzed study population (aged 70 year and above) was composed of Central and North-Eastern Spanish sub-populations obtained from 9 surveys and totaled 12,232 persons and 1,194 cases of dementia (707 of Alzheimer's disease, 238 of vascular dementia). Results showed high variation in age- and sex-specific prevalence across studies. The reanalyzed prevalence of dementia was significantly higher in women; increased with age, particularly for Alzheimer's disease; and displayed a significant geographical variation among men. Prevalence was lowest in surveys reporting participation below 85%, studies referred to urban-mixed populations and populations diagnosed by psychiatrists. Prevalence of dementia and Alzheimer's disease in Central and North-Eastern Spain is higher in females, increases with age, and displays considerable geographic variation that may be method-related. People suffering from dementia and Alzheimer's disease in Spain may approach 600,000 and 400,000 respectively. However, existing studies may not be completely appropriate to infer prevalence of dementia and its subtypes in Spain until surveys in Southern Spain are conducted.

1 April 2005 in Medicina Clinica
Verified
Journal Article
Closed access
MMM. José Medrano
M. José Medrano
ECElena Cerrato
Elena Cerrato
RBRaquel Boix
Raquel Boix
MDMiguel Delgado-Rodríguez
Miguel Delgado-Rodríguez

14 May 2013 in BMJ Open
Verified
Journal Article
Open access
PDF file
IGI Galán
I Galán
RBR Boix
R Boix
MMM J Medrano
M J Medrano
PVPILAR RAMOS VALVERDE
PILAR RAMOS VALVERDE
Francisco RiveraFrancisco Rivera
Francisco Rivera
MRM.Carmen Moreno Rodríguez
M.Carmen Moreno Rodríguez
Objectives Little is known about the dose–response relationship between physical activity and health benefits among young people. Our objective was to analyse the association between the frequency of undertaking moderate-to-vigorous physical activity (MVPA) and the self-reported health status of the adolescent population. Design Cross-sectional study. Setting All regions of Spain. Participants Students aged 11–18 years participating in the Spanish Health Behaviour in School-aged Children survey 2006. A total of 375 schools and 21 188 students were selected. Main outcomes The frequency of undertaking MVPA was measured by a questionnaire, with the following four health indicators: self-rated health, health complaints, satisfaction with life and health-related quality of life. Linear and logistic regression models were used to analyse the association, adjusting for potential confounding variables and the modelling of the dose–response relationship. Results As the frequency of MVPA increased, the association with health benefits was stronger. A linear trend (p<0.05) was found for self-rated health and health complaints in males and females and for satisfaction with life among females; for health-related quality of life this relationship was quadratic for both sexes (p<0.05). For self-reported health and health complaints, the effect was found to be of greater magnitude in males than in females and, in all scales, the benefits were observed from the lowest frequencies of MVPA, especially in males. Conclusions A protective effect of MVPA was found in both sexes for the four health indicators studied, and this activity had a gradient effect. Among males, health benefits were detected from very low levels of physical activity and the magnitude of the relationship was greater than that for females.

19 September 2011 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
AVAlberto Villarejo-Galende
Alberto Villarejo-Galende
JBJulián Benito-León
Julián Benito-León
RTRocío Trincado
Rocío Trincado
IPIgnacio J. Posada
Ignacio J. Posada
VPVeronica Puertas-Martín
Veronica Puertas-Martín
FBFélix Bermejo-Pareja
Félix Bermejo-Pareja
To evaluate the mortality, thirteen years after the baseline wave (1994), of participants suffering dementia in the Neurological Disorders in Central Spain (NEDICES) Cohort Study, we conducted a population-based cohort study in the elderly (65 years and more) with 5,278 screened participants at baseline. Mortality has been evaluated by means of the National Death Registry of Spain at 1-5-2007, 13 years after enrolment. Cox's proportional hazards regression models were used to evaluate the hazard of death according to dementia severity and type, adjusting for potential covariates (gender, age, level of education, and co-morbidity). Survival was estimated using Kaplan-Meier method. Of the 5,278 participants screened at baseline, 306 had dementia. Mortality at 13 years was: 275 deaths (89.9%) in dementia subjects; and 2,426 (49.0%) in subjects without dementia. Mortality was higher and statistically significant in dementia subjects. The degree of dementia (DSM-III-R) correlated with the risk of mortality, from mild (HR = 2.23; CI: 1.77–2.82) to moderate (HR =3.10; CI: 2.47–3.89) and severe dementia (HR = 4.98; CI: 3.85–6.44). Survival was similar in Alzheimer's disease and vascular dementia. Factors associated with higher mortality in Cox proportional hazard models were older age, male gender, and comorbidity. Using Population Attributable risk (PAR%), dementia was related to 11.3% of all deaths. Dementia intensity increases the mortality risk at ten years in the NEDICES Study as in other cohort studies. Age, gender, and co-morbidity are associated with higher mortality in dementia patients. Almost one third of deaths in persons over 85 years-old could be attributable to dementia.

1 December 2007 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
MMMaría J. Medrano
María J. Medrano
PRPastor-Barriuso Roberto
Pastor-Barriuso Roberto
RBRaquel Boix
Raquel Boix
JBJosé L. del Barrio
José L. del Barrio
JDJavier Damián
Javier Damián
AMAlejandro Marín
Alejandro Marín